Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2010-11-29
pubmed:abstractText
The importance of insulin-like growth factor-1 (IGF-1) in coronary artery disease (CAD) due to wide range of its biological effects and its therapeutic potential, has already been described. Our aim was to evaluate possible influence of IGF-1 serum level changes on coronary atherosclerosis. In case of existence of such association our further aim was to verify and explain this phenomenon by examination of promoter P1 of IGF-1gene and receptor gene for IGF-1. The study was performed in 101 consecutive patients undergo for routine coronary angiography. Quantitative and qualitative assessment of coronary atherosclerosis was performed respectively by estimation of the number of culprit lesions in coronary arteries and by Gensini score calculation. IGF-1, IGFBP3 and plasma lipoproteins were measured in all patients. In addition, we evaluated DNA from 101 patients, isolated from blood cells, which was amplified by using PCR with sophisticated primers for P1 promoter of IGF-1 gene and IGF-1 receptor gene, then analyzed utilizing SSCP technique and automatically sequenced. We observed significant increase of serum IGF-1 levels in patients with "3 vessel disease" and with high score in Gensini scale when compared to those without any narrowing lesions in coronary arteries and 0 Gensini score (in group with 3 vessel disease 215.0 ± 71.3 versuss 176.7 ± 34.2 ng/ml p = 0.04 and with high Gensini score 231.4 ± 59.3 versus 181.0 ± 37.8 ng/ml p = 0.01).We found different genotypes for five P1 promoter polymorphisms of IGF-1 gene (RS35767, RS5742612, RS228837, RS11829693, RS17879774). There were no significant associations between the observed single nucleotide polymorphism (SNP) and coronary atherosclerosis nor with levels of circulating IGF-1. We found no structural polymorphism in receptor gene for IGF-1 nor in its extracellular domain(exon 2-4) nor in internal domain (exon 16-21). The effect of increased IGF-1 serum level in our study was probably independent from structural polymorphism in promoter P1 for IGF-1 or in receptor gene for IGF-1.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-10666406, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-10973769, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-11348998, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-11603921, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-12065326, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-12186788, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-12186797, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-14604834, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-15294054, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-15596027, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-16635594, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-1725860, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-19626396, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-20872173, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-8988513, http://linkedlifedata.com/resource/pubmed/commentcorrection/21046444-9484994
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1875-8355
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
538-44
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:21046444-Aged, pubmed-meshheading:21046444-Coronary Angiography, pubmed-meshheading:21046444-Coronary Artery Disease, pubmed-meshheading:21046444-Female, pubmed-meshheading:21046444-Gene Frequency, pubmed-meshheading:21046444-Genetic Association Studies, pubmed-meshheading:21046444-Humans, pubmed-meshheading:21046444-Insulin-Like Growth Factor Binding Protein 3, pubmed-meshheading:21046444-Insulin-Like Growth Factor Binding Proteins, pubmed-meshheading:21046444-Insulin-Like Growth Factor I, pubmed-meshheading:21046444-Lipoproteins, pubmed-meshheading:21046444-Male, pubmed-meshheading:21046444-Middle Aged, pubmed-meshheading:21046444-Polymorphism, Genetic, pubmed-meshheading:21046444-Promoter Regions, Genetic, pubmed-meshheading:21046444-Receptor, IGF Type 1, pubmed-meshheading:21046444-Research Design
pubmed:year
2010
pubmed:articleTitle
Are elevated levels of IGF-1 caused by coronary arteriesoclerosis?: Molecular and clinical analysis.
pubmed:affiliation
Division of Cardiology-Intensive Therapy, Department of Internal Medicine, Poznan University of Medical Sciences, ul. Przybyszewskiego 49, 60-355 Poznan, Poland. pab2@tlen.pl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't